FINANCIAL STATEMENTS
FOR THE QUARTER ENDED
31st March 2024
SINGHE HOSPITALS PLC
(PB 70371 PQ)
Singhe Hospitals PLC
INCOME STATEMENT & STATEMENT OF OTHER COMPREHENSIVE INCOME Period Ended,
31-Mar-2024 | 31-Mar-2023 | |||
Rs. | Rs. | |||
Not Audited | Audited | |||
Revenue | 1,271,872,929 | 1,071,705,911 | ||
Cost of Services | (484,164,596) | (461,081,926) | ||
Gross Profit | ||||
787,708,333 | 610,623,985 | |||
Other Income and Gains | 1,829,547 | 1,789,544 | ||
Administrative Expenses | (600,516,228) | (468,644,034) | ||
Other Operating Expenses | (99,419,229) | (62,969,286) | ||
Finance Cost | (57,497,181) | (64,852,753) | ||
Profit Before Tax | ||||
32,105,242 | 15,947,457 | |||
Income Tax | (32,186,390) | (5,594,590) | ||
Profit/(Loss) for the Period | ||||
(81,148) | 10,352,867 | |||
Items That Will Not be Reclassified to Profit or Loss | ||||
Actuarial Gain/(Loss) from Valuation of Defined Benefit Plans | (2,851,854) | (460,383) | ||
Gain on Revaluation of Land & Building | ||||
Deferred Tax Impact on Defined Benefit Plan Actuarial Gain/(Loss) | 570,371 | 64,454 | ||
Gain on Revaluation of Property Plant & Equipment | 378,247,579 | - | ||
Deferred Tax Impact on Revaluation Gain | (75,649,516) | - | ||
Other Comprehensive Income/ (Expenses) | ||||
300,316,580 | (395,929) | |||
Total Comprehensive Income/ (Loss) for the Period | ||||
300,235,432 | 9,956,938 | |||
Earnings/(Loss) Per Share - Basic | (0.00) | 0.02 | ||
2
Singhe Hospitals PLC
INCOME STATEMENT & STATEMENT OF OTHER COMPREHENSIVE INCOME
Three Months Ended,
31-Mar-2024 | 31-Mar-2023 | |||
Rs. | Rs. | |||
Not Audited | Not Audited | |||
Revenue | 317,693,191 | 301,099,258 | ||
Cost of Services | (137,640,185) | (156,107,013) | ||
Gross Profit | ||||
180,053,007 | 144,992,245 | |||
Other Income and Gains | (494,716) | (1,134,027) | ||
Administrative Expenses | (153,063,300) | (108,891,463) | ||
Other Operating Expenses | (7,729,083) | (20,146,027) | ||
Finance Cost | (9,600,704) | (18,583,335) | ||
Profit Before Tax | ||||
9,165,204 | (3,762,606) | |||
Income Tax | 13,660,868 | 410,864 | ||
Profit/(Loss) for the Period | ||||
22,826,071 | (3,351,742) | |||
Other Comprehensive Income/ (Expenses) | ||||
Actuarial Gain/(Loss) from Valuation of Defined Benefit Plans | (2,851,854) | - | ||
Gain on Revaluation of Land & Building | - | |||
Deferred Tax Impact on Defined Benefit Plan Actuarial Gain/(Loss) | 570,371 | - | ||
Gain on Revaluation of Property Plant & Equipment | 378,247,579 | - | ||
Deferred Tax Impact on Revaluation Gain | (75,649,516) | - | ||
Other Comprehensive Income/ (Expenses) | ||||
300,316,580 | - | |||
Total Comprehensive Income/ (Expenses) | ||||
323,142,651 | (3,351,742) | |||
Earnings/(Loss) Per Share - Basic | 0.05 | (0.01) | ||
3
Singhe Hospitals PLC
STATEMENT OF FINANCIAL POSITION
As at,
31-Mar-2024 | 31-Mar-2023 | ||
ASSETS | Rs. | Rs. | |
Not Audited | Audited | ||
Non-Current Assets | |||
Property, Plant and Equipment | 1,107,195,534 | 730,156,297 | |
Right of Use Assets | 67,914,375 | 54,362,082 | |
Intangible Assets | 11,836,754 | 6,462,625 | |
1,186,946,663 | 790,981,004 | ||
Current Assets | |||
Inventories | 65,018,751 | 110,357,773 | |
Trade and Other Receivables | 53,952,925 | 44,795,323 | |
Financial Investments | 27,235 | 28,265 | |
Short Term Investment | 13,902,268 | 12,000,000 | |
Cash and Bank Balances | 30,498,151 | 23,030,636 | |
163,399,329 | 190,211,997 | ||
Total Assets | 1,350,345,992 | 981,193,001 | |
EQUITY AND LIABILITIES | |||
Capital and Reserves | |||
Stated Capital | 375,000,000 | 375,000,000 | |
Capital Reserves | 409,695,432 | 109,378,852 | |
Retained Earnings | 19,863,026 | 19,944,174 | |
Total Equity | 804,558,458 | 504,323,026 | |
Non-Current Liabilities | |||
Interest Bearing Loans and Borrowings | 147,243,753 | 165,781,071 | |
Lease Liability | 26,887,440 | 16,717,516 | |
Deferred Tax Liabilities | 168,023,751 | 71,186,926 | |
Retirement Benefit Obligations | 16,432,268 | 11,872,980 | |
358,587,213 | 265,558,494 | ||
Current Liabilities | |||
Trade and Other Payables | 72,072,644 | 95,122,656 | |
Interest Bearing Loans and Borrowings | 66,790,782 | 60,127,987 | |
Lease Liability | 17,792,568 | 17,058,267 | |
Bank Overdrafts | 21,379,965 | 34,797,921 | |
Taxation | 9,164,363 | 4,204,650 | |
187,200,322 | 211,311,481 | ||
Total Equity and Liabilities | 1,350,345,992 | 981,193,001 | |
0 | |||
Net Assets Per Share | 1.87 | 1.17 |
The above figures are provisional & subject to audit.
It is certified that the Financial Statements have been prepared in accordance with the requirements of the Companies Act No.7 of 2007.
Sgd.
Asanka De Silva
Finance Manager
The Board of Directors are responsible for the preparation and presentation of these Financial Statements. Approved & Signed on behalf of the Board.
Sgd. | Sgd. |
Navinda Weerasinghe | Lakshika Weerasinghe |
Managing Director | Director |
29.05.2024 | |
Rathnapura |
4
Singhe Hospitals PLC
STATEMENT OF CHANGES IN EQUITY
Period Ended 31st March 2024
Stated | Revaluation | Gain / ( Loss) on | Retained | ||||||
Capital | Reserves | Defined Benefit Plan | Earnings | Total | |||||
Rs. | Rs. | Rs. | Rs. | Rs. | |||||
Balance as at 01st April, 2022 | 375,000,000 | 106,242,881 | 3,531,900 | 9,591,307 | 494,366,088 | ||||
Profit for the Period | - | - | - | 10,352,867 | 10,352,867 | ||||
Other Comprehensive Income | - | - | (460,383) | - | (460,383) | ||||
Deferred Tax Impact on Actuarial Gain/(Loss) | - | - | 64,454 | - | 64,454 | ||||
Balance as at 31st March, 2023 | |||||||||
375,000,000 | 106,242,881 | 3,135,971 | 19,944,174 | 504,323,026 | |||||
Profit for the Period | - | - | - | (81,148) | (81,148) | ||||
Other Comprehensive Income | - | 378,247,579 | (2,851,854) | - | 375,395,725 | ||||
Deferred Tax Impact on Actuarial Gain/(Loss) | - | - | 570,371 | - | 570,371 | ||||
Deferred Tax on Revaluation | - | (75,649,516) | - | - | (75,649,516) | ||||
Balance as at 31st March, 2024 | 375,000,000 | 408,840,944 | 854,488 | 19,863,026 | 804,558,458 | ||||
5
Singhe Hospitals PLC
CASH FLOW STATEMENT
Year Ended,
31-Mar-2024 | 31-Mar-2023 | ||
Cash Flows From Operating Activities | Rs. | Rs. | |
Profit/(Loss) Before Income Tax Expense | 32,105,242 | 15,947,457 | |
Adjustments for | |||
Depreciation & Amortization | 73,700,330 | 76,488,443 | |
Provision for Retirement Gratuity | 4,625,094 | 3,807,386 | |
Finance Expense | 57,497,181 | 64,852,753 | |
Interest Income | (1,499,274) | (1,112,332) | |
Bad debts written off | 751,455 | 57,416 | |
Fair Value (Gain)/Loss on Quoted Investments | 1,030 | (7,545) | |
Stocks Written Off | 3,778,358 | - | |
Operating Profit Before Working Capital Changes | 170,959,415 | 160,033,578 | |
Changes in Working Capital | |||
(Increase)/Decrease in Inventories | 41,560,658 | (25,407,788) | |
Increase/(Decrease) in Amount Due to Related Parties | - | (672,111) | |
(Increase)/Decrease in Trade and Other Receivables | (9,909,057) | (6,229,085) | |
Increase/(Decrease) in Trade and Other Payables | (23,050,012) | 57,066,395 | |
Cash Generated From Operations | 179,561,004 | 184,790,989 | |
Income Tax Paid | (5,425,290) | - | |
Finance Costs Paid | (57,497,181) | (64,852,753) | |
Defined Benefit Plan Costs Paid | (2,917,660) | (2,450,056) | |
WHT Paid | (43,708) | (25,206) | |
Net Cash From Operating Activities | 113,677,165 | 117,462,972 | |
Cash Flows From/(Used in) Investing Activities | |||
Acquisition of Property, Plant and Equipment | (42,436,447) | (40,168,451) | |
Acquisition of Capital Work in Progress | (3,951,140) | (2,162,948) | |
Acquisition of Capital Work in Progress - Intangible Assets | (3,128,500) | (70,000) | |
Acquisition of Intangible Assets | (3,857,483) | (750,000) | |
Acquisition of Right of Use Assets | (38,044,837) | (8,899,024) | |
Income From Investments - Interest Received | 1,499,274 | 1,112,332 | |
Investment in Fixed Deposit | (1,902,268) | (12,000,000) | |
Net Cash Flows From/(Used in) Investing Activities | (91,821,401) | (62,938,091) | |
Cash Flows from /(Used in) Financing Activities | |||
Net Proceeds from Interest Bearing Borrowings | (11,874,523) | (9,118,045) | |
Proceeds from Leases | 45,915,525 | 12,665,493 | |
Repayments of Leases Liability | (35,011,297) | (31,498,967) | |
Net Cash Flows from/(Used in) Financing Activities | (970,295) | (27,951,519) | |
Net Increase/(Decrease) in Cash and Cash Equivalents | 20,885,470 | 26,573,363 | |
Cash and Cash Equivalents at the Beginning of the Year | (11,767,284) | (38,340,647) | |
Cash and Cash Equivalents at the End of the Year | 9,118,186 | (11,767,284) | |
Cash & Cash Equivalents | |||
Cash at Bank | 17,693,143 | 3,265,877 | |
Bank Overdrafts | (21,379,965) | (34,797,921) | |
Cash in Hand | 12,805,008 | 19,764,760 | |
Cash and Cash Equivalents at the End of the Year | 9,118,186 | (11,767,284) | |
6
Singhe Hospitals PLC
NOTES TO THE INTERIM FINANCIAL STATEMENTS
01. Singhe Hospitals PLC ("Company") is a quoted public Company with limited liability incorporated in Sri Lanka under the provisions of Companies Act No. 07 of 2007. Its registered office and principal place of business are located at No: 362, Colombo Road, Rathnapura.
02. The interim condensed financial statements have been prepared in accordance with Sri Lanka Accounting Standard - LKAS 34 Interim Financial Reporting. These interim condensed financial statements should be read in conjunction with the annual financial statements for the year ended 31 March 2023. These financial statements provide the information as required in terms of Rule 7.4 of the Colombo Stock Exchange. Further , Provisions of the Companies Act No 7 of 2007 have been considered in preparing the interim financial statements of the Company.
03. Figures disclosed in the interim financial statements are provisional and subject to audit.
04. The presentation and classification of the Financial Statements of the previous year have been amended, where relevant, for better presentation and to be comparable with those of the current year.
05. The Interim Condensed Financial Statements of the Company for the period ended 31st March 2024 were authorised for issue by the Board of Directors on 29.05.2024
06. Issued and fully paid number of Ordinary Shares as at 31st March 2024 stands at 431,300,895.
07. There were no material commitments outstanding as at 31st March 2024 for future capital expenditure.
08. There were no material events that occurred after the reporting date that require adjustments or disclosure to the Financial Statements. Other than above.
- There were no significant changes in the nature of the contingent liabilities and contingent assets which were disclosed in the Annual Report for the year ended 31st March 2023.
- There have been no other events, which require disclosure in the Interim Financial Statements.
- The key management personnel of the company are the members of its Directors.
Key Management Personnel Compensation | As at | As at | |
31st March 2024 | 31st March 2023 | ||
Short Team Employee Benefit | 1,746,000 | 1,746,000 | |
Post Employment Benefits | Nil | Nil | |
Interest Bearing Loan And Borrowings | As at | As at | |
31st March 2024 | 31st March 2023 | ||
Bank Term Loan with in One year | 66,790,782 | 60,127,987 | |
Bank Term Loan after One year | 147,243,753 | 165,781,071 | |
Bank Term Loan | 214,034,535 | 225,909,058 |
7
Singhe Hospitals PLC
NOTES TO THE INTERIM FINANCIAL STATEMENTS
As at | As at | |||||
31st March 2024 | 31st March 2023 | |||||
No of Ordinary Shares | 431,300,895 | 431,300,895 | ||||
Market Value of Shares | ||||||
As at | As at | |||||
Date | 31st March 2024 | 31st March 2023 | ||||
Highest Price per Share - Rs. | 28.03.2024 | 2.40 | 3.00 | |||
Lowest Price Per Share - Rs. | 18.03.2024 | 2.10 | 2.50 | |||
Last Traded Price per Share - Rs. | 28.03.2024 | 2.30 | 2.60 | |||
Directors Shareholding | ||||||
Name Of Director | As at | As at | ||||
31st March 2024 | 31st March 2023 | |||||
Mr. A.M. Weerasinghe | 372,697,415 | 372,697,415 | ||||
Mr. A.M.D.H.N.Weerasinghe | 10 | 10 | ||||
Mr. A.M.L.M. Weerasinghe | 50,000 | 50,000 | ||||
Mr. U.B.H.J. Kithsiri | 1,100,000 | 1,100,000 | ||||
373,847,425 | 373,847,425 | |||||
Public Holding Information | As at | As at | ||||
31st March 2024 | 31st March 2023 | |||||
Issued Share Capital | 431,300,895 | 431,300,895 | ||||
Less | ||||||
Directors Shareholding | 373,847,425 | 373,847,425 | ||||
Related Party Company | 285,074 | 285,074 | ||||
Public Holding | 57,168,396 | 57,168,396 | ||||
Public Holding as a percentage of Issued Share Capital | 13.25% | 13.25% | ||||
Number of Public Shareholders | 1,418 | 1,376 | ||||
Percentage of Total Public Holding | 13.25% | 13.25% | ||||
Major Shareholdings | ||||||
Twenty Largest Shareholders | ||||||
As at | % | As at | % | |||
Name of the Shareholder | Country of Residence | 31st March 2024 | 31st March 2023 | |||
01 | Mr. A. M. Weerasinghe | Sri Lanka | 372,697,415 | 86.41% | 372,697,415 | 86.41% |
02 | Hatton National Bank PLC/Almas Holdings (PVT) LTD | Sri Lanka | 14,831,860 | 3.44% | 18,231,720 | 4.23% |
03 | DFCC Bank PLC/G.A.C De Silva | Sri Lanka | 5,480,000 | 1.27% | 5,345,875 | 1.24% |
04 | Mr.A.S. Jayasinghe | Sri Lanka | 0.49% | |||
05 | Hatton National PLC/Madhura Supun Hiripitiya | Sri Lanka | 0.37% | |||
06 | Mr. K. K. D. P. A. P. Weligepola | Sri Lanka | 0.35% | |||
07 | Mr. A.M.C.S Atapattu | Sri Lanka | 4,406,379 | 1.02% | 2,990,049 | 0.69% |
08 | Mr.A.S. Jayasinghe | Sri Lanka | 2,133,599 | 0.49% | 2,133,599 | 0.49% |
09 | Assetline Finance Limited/M. S. Hiripitiya | Sri Lanka | 1,631,248 | 0.38% | 1,920,534 | 0.45% |
10 | Mr. K. K. D. P. A. P. Weligepola | Sri Lanka | 1,497,101 | 0.35% | 1,497,101 | 0.35% |
11 | Mr. W.A.S.P. De Saram | Sri Lanka | 1,378,759 | 0.32% | 1,430,363 | 0.33% |
12 | Mr. U.B.H.J. Kithsiri | Sri Lanka | 1,100,000 | 0.26% | 1,100,000 | 0.26% |
13 | Hatton National Bank PLC/A. P. Lasantha Fernando | Sri Lanka | 1,100,000 | 0.26% | 1,000,000 | 0.23% |
14 | Senkadagala Finance PLC/Mr. S. Gobinath | Sri Lanka | 1,000,000 | 0.23% | 999,998 | 0.23% |
15 | Techtron Intergrated Solutions (PVT) LTD | Sri Lanka | 893,430 | 0.21% | 793,430 | 0.18% |
16 | Mr. G.P.D.M. Pathiraja | Sri Lanka | 808,151 | 0.19% | 654,780 | 0.15% |
17 | Mr. D.F.H.K. Perera | Sri Lanka | 539,896 | 0.13% | ||
18 | Mr. P.R. De Silva | Sri Lanka | 528,256 | 0.12% | ||
19 | Dr. G.S.Perera | Sri Lanka | 511,224 | 0.12% | 511,224 | 0.12% |
20 | Mr. K. B. Kannangara | Sri Lanka | 500,000 | 0.12% | 500,000 | 0.12% |
21 | Dialog Finance PLC/M.M.S. Asela | Sri Lanka | 487,674 | 0.11% | ||
22 | Hatton National Bank PLC/Ravindra Erle Rambukwelle | Sri Lanka | 480,000 | 0.11% | 480,000 | 0.11% |
23 | Mr. L. E. Liyanage | Sri Lanka | 436,000 | 0.10% | ||
24 | Mr. P.R. De Silva | Sri Lanka | 528,256 | 0.12% | 443,521 | 0.10% |
25 | Mr. L. E. Liyanage | Sri Lanka | 436,000 | 0.10% | ||
26 | Mr. D.R.K. Jayawardana | Sri Lanka | 377,989 | 0.09% | ||
27 | Mr. D.U.J. Jayawardana | Sri Lanka | 364,000 | 0.08% | ||
28 | Mr. G.P.D.M. Pathiraja | Sri Lanka | ||||
Total | ||||||
412,969,248 | 95.76% | 413,907,598 | 97.18% |
The Float- adjusted market capitalization as at 31st March is Rs. 131,487,310 and the Company is in compliance with option 2 of the Listing Rules 7.13.1 (b) which requires 10% minimum public holding percentage and 200 minimum public shareholders.
8
Singhe Hospitals PLC
Corporate Information
Name of the Company | SINGHE HOSPITALS PLC |
Register Office | 362,Colombo Road,Ratnapura. |
Telephone Number | 0457 555 555 |
Email Address | info@singhehospitals.com |
Web Address | www.singhehospital.com |
Incorporation Number | PB 70371 PQ |
Date of Incorporation | 2009 December 16 |
Board of Directors | Mr. A.M. Weerasinghe |
Mr.A. M. D. H. Navinda Weerasinghe | |
Mr.U. B. H. Jayalath Kithsiri | |
Mr.A. M. L. Maduranga Weerasinghe | |
Mr.H.M.A.B. Weerasekara | |
Mr.A.M.A.Cader | |
Mr.A. M. P. N. Weerasinghe | |
Mr. D.T. Gooneratne - (Has resigned on 18th April 2024) | |
Dr. A.C. Jayakody | |
Secretary to Company | Nexia Corporate Consultant (Pvt) Ltd |
No. 130, 2nd Floor, Nawala Road, | |
Narahenpita, | |
Colombo 5. | |
Auditors | BR De Silva & Company, |
22/4, Vijaya Kumaranatunga Mawatha, | |
Colombo 5. | |
Banks | Bank of Ceylon |
Commercial Bank of Ceylon PLC | |
Hatton National Bank PLC | |
Sampath Bank PLC | |
Nation Trust Bank | |
Registrars | SSP Corporate Servicers (Pvt) Ltd |
546/7, Galle Road, | |
Colombo 03. |
9
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Singhe Hospital plc published this content on 29 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 May 2024 09:43:00 UTC.